HTG Molecular Diagnostics
HTGM
$1.23
Share price
6.03%
Change (1 day)
-80.69%
Change (1 year)
Categories
Revenue for HTG Molecular Diagnostics (HTGM)
Revenue in 2022 (TTM): $8.65 M
According to HTG Molecular Diagnostics 's latest financial reports the company's current revenue (TTM) is $8.65 M. In 2021 the company made a revenue of $8.9 M an increase over the years 2020 revenue that were of $8.54 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for HTG Molecular Diagnostics from 2014 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $8.65 M | -2.81% |
| 2021 | $8.9 M | 4.19% |
| 2020 | $8.54 M | -55.48% |
| 2019 | $0.01 B | -10.7% |
| 2018 | $0.02 B | 45.69% |
| 2017 | $0.01 B | 187.56% |
| 2016 | $5.13 M | 38.13% |
| 2015 | $3.71 M | 62.59% |
| 2014 | $2.28 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Lexicon Pharmaceuticals
LXRX | $0.1 M | -98.74% | 🇺🇸 USA |
 Affimed
AFMD | $0.04 B | 388.05% | 🇩🇪 Germany |
 Calithera Biosciences
CALA | $9.75 M | 12.64% | 🇺🇸 USA |